Global Eye Drops (Artificial Tear) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Eye Drops (Artificial Tear) Market Research Report 2024
Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
According to Mr Accuracy reports’s new survey, global Eye Drops (Artificial Tear) market is projected to reach US$ 4090.1 million in 2029, increasing from US$ 3151 million in 2022, with the CAGR of 3.7% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Eye Drops (Artificial Tear) market research.
The artificial tears and lubricants market is driven by the increasing prevalence of dry eye syndrome and the growing awareness of the importance of ocular health. Artificial tears and lubricants are eye drops and ointments used to alleviate dryness and discomfort in the eyes caused by various factors, including aging, digital device use, and environmental conditions. The rise in the aging population and the prevalence of conditions like Sjögren's syndrome contribute to market growth as artificial tears provide relief and improve ocular surface health. Moreover, advancements in formulation technology and the development of preservative-free and longer-lasting products have enhanced their efficacy and patient compliance. However, the market also faces challenges, including the need for proper diagnosis and patient education to ensure appropriate product selection and usage. Additionally, addressing competition from alternative dry eye treatments and maintaining affordable pricing can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective artificial tears and lubricants, collaborate with eye care professionals to promote their benefits, and address the challenges to meet the increasing demand for ocular health solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Eye Drops (Artificial Tear) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Segment by Type
Allergy Eye Care
Standard Eye Care
Pharmacy
Internet
Grocery
Optical Chains
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Eye Drops (Artificial Tear) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Eye Drops (Artificial Tear) market is projected to reach US$ 4090.1 million in 2029, increasing from US$ 3151 million in 2022, with the CAGR of 3.7% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Eye Drops (Artificial Tear) market research.
The artificial tears and lubricants market is driven by the increasing prevalence of dry eye syndrome and the growing awareness of the importance of ocular health. Artificial tears and lubricants are eye drops and ointments used to alleviate dryness and discomfort in the eyes caused by various factors, including aging, digital device use, and environmental conditions. The rise in the aging population and the prevalence of conditions like Sjögren's syndrome contribute to market growth as artificial tears provide relief and improve ocular surface health. Moreover, advancements in formulation technology and the development of preservative-free and longer-lasting products have enhanced their efficacy and patient compliance. However, the market also faces challenges, including the need for proper diagnosis and patient education to ensure appropriate product selection and usage. Additionally, addressing competition from alternative dry eye treatments and maintaining affordable pricing can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective artificial tears and lubricants, collaborate with eye care professionals to promote their benefits, and address the challenges to meet the increasing demand for ocular health solutions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Eye Drops (Artificial Tear) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Segment by Type
Allergy Eye Care
Standard Eye Care
Segment by Application
Pharmacy
Internet
Grocery
Optical Chains
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Eye Drops (Artificial Tear) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices